Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL232 Target Snapshot

Alpha-1B adrenergic receptor · SINGLE PROTEIN · Homo sapiens

2,517Compounds
429Assays
45Approved Drugs
2,333.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P35368. Use UniProt P35368 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P35368 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Alpha-1B adrenergic receptor as ChEMBL target CHEMBL232, mapped to UniProt P35368. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Alpha-1B adrenergic receptor
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL232
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P35368
Alpha-1B adrenergic receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Alpha-1B adrenergic receptor is the right protein anchor across sources, using UniProt P35368 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAlpha-1B adrenergic receptor
UniProt AccessionP35368
Component TypeProtein
Sequence Length520 aa

Alpha-1B adrenergic receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Alpha-1B adrenergic receptor, mapped to UniProt P35368. Sequence length is 520 aa.

Mapped IDP35368
Review nameAlpha-1B adrenergic receptor
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

45
Approved
3
Phase III
17
Phase II
Assay Mix

Activity Type Distribution

IC50202.0
KI1,849.0
EC50269.0
KD13.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2 10.57 Ki 0.027 Approved
CHEMBL25554 10.42 Ki 0.038 Preclinical
CHEMBL42472 10.4 Ki 0.03981 Preclinical
CHEMBL342062 10.15 Ki 0.07079 Preclinical
CHEMBL324090 10.1 Ki 0.08 Clinical
CHEMBL5618291 10.07 Ki 0.086 Preclinical
CHEMBL3582270 10.0 Ki 0.1 Preclinical
CHEMBL27013 9.96 Ki 0.1096 Preclinical
CHEMBL836 9.89 EC50 0.13 Approved
CHEMBL4126860 9.89 Ki 0.1288 Preclinical
Distribution

pChEMBL Value Distribution

103
5.0
164
5.5
292
6.0
373
6.5
320
7.0
190
7.5
131
8.0
87
8.5
70
9.0
27
9.5
pChEMBL
Approved Drugs

Approved Drugs

LUMATEPERONE TOSYLATE
CHEMBL3233142
Approved 2019
BREXPIPRAZOLE
CHEMBL2105760
Approved 2015
SILODOSIN
CHEMBL24778
Approved 2008
ALFUZOSIN
CHEMBL709
Approved 2003
ARIPIPRAZOLE
CHEMBL1112
Approved 2002
NAFTOPIDIL
CHEMBL142635
Approved 1999
TAMSULOSIN
CHEMBL836
Approved 1997
QUETIAPINE
CHEMBL716
Approved 1997
AZELASTINE
CHEMBL639
Approved 1996
OLANZAPINE
CHEMBL715
Approved 1996
NEFAZODONE HYDROCHLORIDE
CHEMBL1200492
Approved 1994
RISPERIDONE
CHEMBL85
Approved 1993
DOXAZOSIN
CHEMBL707
Approved 1990
CLOZAPINE
CHEMBL42
Approved 1989
TERAZOSIN
CHEMBL611
Approved 1987
OXYMETAZOLINE
CHEMBL762
Approved 1986
PRAZOSIN HYDROCHLORIDE
CHEMBL1558
Approved 1976
PRAZOSIN
CHEMBL2
Approved 1976
EPINEPHRINE
CHEMBL679
Approved 1965
PHENTOLAMINE
CHEMBL597
Approved 1952
PHENYLEPHRINE
CHEMBL1215
Approved 1952
DIHYDROERGOTAMINE MESYLATE
CHEMBL1200517
Approved 1946
Assay Landscape

Assay Landscape

429
Total Assays
1,365
Tested Compounds
3
Assay Types
Binding — 358 assays, 1,365 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 241 600 6.8
cell-based format 100 548 7.3
tissue-based format 10 133 7.1
assay format 5 77 6.4
cell membrane format 2 7 7.0
Functional — 62 assays, 167 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 29 66 6.6
assay format 28 88 7.3
tissue-based format 5 13 6.2
ADME — 9 assays, 45 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 9 45 7.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine